Alumis Inc. Common Stock
General ticker "ALMS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.1B (TTM average)
Alumis Inc. Common Stock follows the US Stock Market performance with the rate: 41.1%.
Estimated limits based on current volatility of 2.9%: low 19.57$, high 20.75$
Factors to consider:
- Total employees count: 170 as of 2024
- Current price 27.3% above estimated high
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [5.50$, 14.97$]
- 2026-12-31 to 2027-12-31 estimated range: [3.86$, 10.99$]
Short-term ALMS quotes
Long-term ALMS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $24.05MM |
| Operating Expenses | $158.17MM | $300.75MM | $477.85MM |
| Operating Income | $-158.17MM | $-300.75MM | $-453.80MM |
| Non-Operating Income | $3.18MM | $6.52MM | $201.92MM |
| R&D Expense | $137.68MM | $265.55MM | $386.00MM |
| Income(Loss) | $-154.99MM | $-294.23MM | $-251.89MM |
| Taxes | $0.00MM | $0.00MM | $-8.56MM |
| Net Income(Loss)* | $-154.99MM | $-294.23MM | $-243.32MM |
| Stockholders Equity | $-339.26MM | $260.10MM | $301.30MM |
| Assets | $89.61MM | $340.99MM | $411.94MM |
| Operating Cash Flow | $-129.97MM | $-255.08MM | $-369.52MM |
| Capital expenditure | $4.50MM | $1.73MM | $0.65MM |
| Investing Cash Flow | $60.47MM | $-113.79MM | $287.88MM |
| Financing Cash Flow | $89.68MM | $492.37MM | $2.07MM |
| Earnings Per Share** | $-2.99 | $-10.38 | $-0.29 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.